首页 | 本学科首页   官方微博 | 高级检索  
     

白念珠菌V-ATPase研究进展
引用本文:周密,;康烨,;阎澜,;姜远英. 白念珠菌V-ATPase研究进展[J]. 中国真菌学杂志, 2014, 0(3): 177-181
作者姓名:周密,  康烨,  阎澜,  姜远英
作者单位:[1]第二军医大学药学院新药研究中心,上海200433; [2]沈阳军区总医院北陵临床部,沈阳110031
摘    要:白念珠菌是临床最常见的条件致病真菌,V-ATPase是真核生物中高度保守的质子泵转运复合物,可以维持液泡和细胞质pH稳态.近年来,V-ATPase作为一个抗白念珠菌感染的潜在靶点为人们所关注,本文就V-ATPase抑制剂、相关的其他靶点及抑制剂筛选等方面的研究进展作一综述.

关 键 词:白念珠菌  液泡  V-ATPase

Progress of V-ATPase in Candida albicans
Affiliation:ZHOU Mi(New Drug R & D Center,School of Pharmacy,Second Military Medical University,Shanghai 200433,China) KANG Ye(General Hospital of Shenyang Military Region, Beijing Clinical Department, Shenyang 110031, China) YAN Lan(New Drug R & D Center,School of Pharmacy,Second Military Medical University,Shanghai 200433,China) JIANG Yuan-ying(New Drug R & D Center,School of Pharmacy,Second Military Medical University,Shanghai 200433,China)
Abstract:Candida albicans is the most common opportunistic fungal pathogen in humans.V-ATPase is one of the proton transporter complexes,which is highly conserved in eukaryotes.V-ATPase sustains the pH steady between cytosolic and vacuolar.Recently V-ATPase has been concerned as a potential target in C.albicans.This article reviews its research progress.
Keywords:Candida albicans  vacuole  V-ATPase
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号